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a b s t r a c t
H6N1 avian inﬂuenza viruses (AIVs) may pose a potential human risk as suggested by the ﬁrst
documented naturally-acquired human H6N1 virus infection in 2013. Here, we set out to elucidate viral
determinants critical to the pathogenesis of this virus using a mouse model. We found that the
recombinant H6N1 viruses possessing both the PA-T97I and PB2-E627K substitutions displayed the
greatest enhancement of replication in vitro and in vivo. Polymerase complexes possessing either
PB2-E627K, PA-T97I, and PB2-E627K/PA-T97I displayed higher virus polymerase activity when compared
to the wild-type virus, which may account for the increased replication kinetics and enhanced virulence
of variant viruses. Our results demonstrate that PB2-E627K and PA-T97I enhance the ability of H6N1
virus to replicate and cause disease in mammals. Inﬂuenza surveillance efforts should include scrutiny of
these regions of PB2 and PA because of their impact on the increased virulence of H6N1 AIVs in mice.
& 2014 Elsevier Inc. All rights reserved.
Introduction
H6 subtypes of inﬂuenza viruses are the most abundantly detected
inﬂuenza virus subtype, and are associated with a broader host range
than any other inﬂuenza subtype (Munster et al., 2007; Spackman
et al., 2005). The ﬁrst human case of H6N1 AIV infection have been
reported in Taiwan in 2013 (Myers et al., 2007). A recent report also
demonstrated that some H6 viruses could transmit between guinea
pigs by direct contact (Wang et al., 2014). Taken together, the reported
case of human infection with an H6 subtype virus, the ability of some
H6 viruses to transmit between mammals, and a lack of pre-existing
immunity to H6 inﬂuenza viruses in humans suggest that H6 AIVs
may pose a pandemic threat. Sporadic infection of mammalian species
with avian inﬂuenza viruses provides an opportunity for avian viruses
to adapt to a new host environment and potentially acquire adaptive
changes leading to the emergence of a pandemic virus. Therefore, a
more complete understanding of the molecular features involved in
the host range restriction and mammalian adaptation of H6 AIVs
should be further studied.
Mice provide an excellent model in which to study of the
mechanisms of inﬂuenza virus adaptation (Blazejewska et al.,
2011; Gabriel et al., 2005; Hatta et al., 2001; Jiao et al., 2008; Li
et al., 2005; Liu et al., 2014; Llompart et al., 2014; Lu et al., 1999;
Memoli et al., 2009; Metreveli et al., 2014; Qi et al., 2012; Song et al.,
2009; Tarnow et al., 2014; Tumpey et al., 2005; Watanabe et al.,
2013; Zaraket et al., 2013; Zhang et al., 2012a). In a previous study,
to identify changes that are associated with the adaptation of H6N1
AIV to mammalian hosts, we had serially passaged a mallard origin
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H6N1 virus in mice, and after sequential passage of this virus in
mice, we obtained two mouse-adapted viruses, which named MA-
P8M1 and MA-P8M3. In this study, we found that the MA-P8M3
displayed increased virulence and a novel amino acid substitution
combination (PB2-E627K and PA-T97I) in the viral RNA-dependent
RNA polymerase (RDRP) complex that was sufﬁcient for increasing
the pathogenicity of the H6N1 AIVs. In vitro and in vivo analyses
demonstrated that this substitution combination signiﬁcantly
enhanced RNA polymerase activity and viral replication. Therefore,
this combination of adaptive mutations in the PA and PB2 gene
contribute to mammalian adaptation of H6N1 AIVs.
Results
Mouse adapted H6N1 variant is high pathogenic for mice
We compared the pathogenicity of the parental virus WT H6N1
SJ/275 virus with the mouse-adapted variant MA-P8M3 in mice.
Mice were infected intranasally with 104 EID50 or 105 EID50 doses
of WT SJ/275 or MA-P8M3, and were followed for 14 days for body
weight loss and mortality. A group of mock-infected mice were
included as a control. Mice that lost 425% of their initial body
weight were considered moribund and were euthanized. At doses
of 105 EID50 and 104 EID50, mice infected with WT SJ/275 survived
infection and did not show any appreciable weight loss (Fig. 1),
whereas mice infected with 105 EID50 and 104 EID50 of the mouse-
adapted MA-P8M3 variant rapidly lost weight and succumbed to
infection (Fig. 1). Based on these data, we found that serial passage
of WT SJ/275 resulted in substantially increased virulence in mice.
Sequence analysis
We identify three adaptive mutations in the genomes of the
MA-P8M3. The MA-P8M3 viruses had an E-K substitution at PB2
position 627, and a T-I substitution amino at PA position 97, and
an N-T substitution at HA position 394.
PB2-E627K and PA-T97I substitutions enhance viral replicatio-
nin MDCK cells
The PB2, PA, and HA gene segments from the MA-P8M3 virus
and the PB1, NP, NA, M, and NS gene segments from the WT SJ/275
virus were cloned into plasmids for reverse genetics in order to
produce recombinant viruses and determine the contribution of
each amino acid substitution to the enhanced virulence of the
mouse-adapted H6N1 viruses. We ﬁrst compared the in vitro
replication kinetics of the WT SJ/275 virus to three recombinant
viruses generated by reverse genetics: one incorporating the PB2
E627K substitution (rSJ/275-P8M3-PB2), one incorporating the PA
T97I substitution (rSJ/275-P8M3-PA), and one incorporating the
HA N394T substitution (rSJ/275-P8M3-HA) (Table 1). The recom-
binant viruses all replicated with kinetics similar to that of the WT
SJ/275 virus, although the rSJ/275-P8M3-PB2 virus achieved
higher titers at 24 h post-inoculation (Fig. 2A).
We then generated recombinant viruses with different combi-
nations of mouse-adaptive amino acid substitutions to determine
if there was a combinatorial effect of multiple substitutions on
viral growth kinetics in MDCK cells (Table 1). Whereas the
recombinant virus with only the PB2-E627K substitution repli-
cated with similar kinetics as the WT SJ/275 virus in MDCK cells
(Fig. 2A), the presence of both the PB2-E627K and PA-T97I amino
acid substitutions, either with or without the HA-N394T substitu-
tion, resulted in increased viral titers in MDCK cells when
compared to the WT SJ/275 virus (Fig. 2C). Recombinant viruses
that did not harbor the PB2-E627K substitution but possessed the
PA-T97I or HA-N394T substitution either alone or in combination
showed similar growth kinetics to the WT SJ/275 virus. Taken
together, these data indicate that PB2-E627K in conjunction
with PA-T97I enhanced viral replication in MDCK cells (Fig. 2A
and C).
PB2-E627K and PA-T97I substitutions enhance viral replication in
mice
We then evaluated the in vivo replicative capacity of each
recombinant virus by inoculating mice with 104 EID50 of each virus
and analyzing virus titers in the lungs on days 3 and 5 post-
infection (Fig. 3A). The WT SJ/275 virus was not detected in the
lungs of inoculated mice at day 3 or 5 post-infection (Fig. 3A).
Highest viral titers in the lung at both time points were found in
mice infected with recombinant viruses possessing both PB2-
E627K and PA-T97I (Fig. 3A). Recombinant viruses possessing
either the PB2-E627K or PA-T97I substitution in isolation resulted
Fig. 1. Increased virulence of mouse-adapted H6N1 virus in mice. Mice (n¼5) were
inoculated intranasally with 50 μl containing 104 or 105 EID50 of mouse-adapted
viruses (MA-P8M3) or the parental wild-type H6N1 virus (WT) or mock inoculated
(Mock; n¼5), and animals that lost more than 25% of their pre-infection weight
were euthanized. Morbidity was examined by recording the body weights of
inoculated mice daily, and it is represented as a percentage of the weight on the
day of inoculation (day 0). The average of each group is shown. The numbers in the
graphs indicated the numbers of surviving mice per group.
Table 1
Comparison of amino acid and MLD50 differences between wild-type SJ/275 and
recombinant H6N1 viruses.
Virusa PB2 PA HA MLD50
627 97 394
WT SJ/275 E T N 46.5
rSJ/275-P8M3-PB2 K T N 4.5
rSJ/275-P8M3-PA E I N 46.5
rSJ/275-P8M3-HA E T T 46.5
rSJ/275-P8M3-PB2/PA K I N 3.25
rSJ/275-P8M3-PB2/HA K T T 5
rSJ/275-P8M3-PA/HA E I T 5.5
rSJ/275-P8M3-PB2/PA/HA K I T 3.5
a WT SJ/275, A/Mallard/SanJiang/275/2007(H6N1); MA-P8M3, mouse-adapted
SJ/275; We constructed the WT SJ/275-PB2, the WT SJ/275-PB1, the WT SJ/275-PA,
the WT SJ/275-HA, the WT SJ/275-NP, the WT SJ/275-NA, the WT SJ/275-M, the WT
SJ/275-NS, the MA-P8M3-PB2, the MA-P8M3-PA, and the MA-P8M3-HA plasmids,
respectively. These plasmids were used for transfection to rescue the recombinant
viruses in this study. rSJ/275-P8M3-PB2, recombinant carrying the PB2 gene from
MA-P8M3 and remaining 7 genes from WT SJ/275; rSJ/275-P8M3-PA, recombinant
carrying the PA gene from MA-P8M3 and remaining 7 genes from WT SJ/275; rSJ/
275-P8M3-HA, recombinant carrying the HA gene from MA-P8M3 and remaining
7 genes from WT SJ/275; rSJ/275-P8M3-PB2/PA, recombinant carrying the PB2 and
PA genes from MA-P8M3 and remaining 6 genes from WT SJ/275; rSJ/275-P8M3-
PB2/HA, recombinant carrying the PB2 and HA genes from MA-P8M3 and remain-
ing 6 genes from WT SJ/275; rSJ/275-P8M3-PA/HA, recombinant carrying the PA
and HA genes from MA-P8M3 and remaining 6 genes from WT SJ/275; rSJ/275-
P8M3-PB2/PA/HA, recombinant carrying the PB2, PA, and HA genes from MA-P8M3
and remaining 5 genes from WT SJ/275.
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in lung viral titers approximately 10-fold less than viruses harbor-
ing both substitutions together regardless of whether the viruses
also included the HA-N394T substitution (Fig. 3A). The recombi-
nant virus possessing the HA-N394T substitution alone was not
detectable in the lungs of mice on days 3 or 5 post-infection
(Fig. 3A).
PB2-E627K and PA-T97I substitutions enhance virulence and expand
the tropism of an H6N1 virus in mice
Cohorts of mice were infected with 106 EID50 of WT SJ/275 or a
recombinant virus harboring one of the mouse-adapting amino acid
substitutions and were followed for 14 days to evaluate weight loss
and survival (Fig. 2B). Mice inoculated with WT SJ/275 and rSJ/275-
P8M3-HA lost little weight and survived infection (Fig. 2B). In
contrast, mice infected with rSJ/275-P8M3-PB2 rapidly lost weight
and succumbed to infection by day 6 post-infection (Fig. 2B). The
rSJ/275-P8M3-PA virus elicited appreciable weight loss in mice, but
was not lethal (Fig. 2B). We determined the WT SJ/275 virus MLD50
was 46.5 log10 EID50, and the MLD50 of the rSJ/275-P8M3-PB2, rSJ/
275-P8M3-PA, and rSJ/275-P8M3-HA viruses were 4.5 log10 EID50,
46.5 log10 EID50, and 46.5 log10 EID50, respectively (Table 1),
indicating that PB2-E627K resulted in increased virulence in mice.
Mice were inoculated with 106 EID50 of WT SJ/275 or recombi-
nant viruses harboring different combinations of the mouse-
adaptive amino acid substitutions and were followed for weight
loss and survival. In contrast to mice inoculated with WT SJ/275
which lost little weight and survived infection, infection of mice
with any recombinant virus possessing PB2-E627K resulted in
rapid weight loss and signiﬁcant mortality (Fig. 2D). In addition
including the PA-T97I and/or HA-N394T amino acid substitutions
with PB2-E627K in the recombinant viruses did not signiﬁcantly
alter the pattern of weight loss or survival when compared
to viruses harboring PB2-E627K alone, demonstrating that the
Fig. 2. Effects of amino acid mutations for replication and virulence of SJ/275. The parental SJ/275H6N1 virus and recombinant viruses possessing one or more of the amino
acid substitutions identiﬁed in mouse-adapted viral variants were generated by reverse genetics. A-B) The parental SJ/275H6N1 virus (SJ/275) and recombinant viruses
possessing PB2-E627K (rSJ/275-P8M3-PB2), PA-T97I (rSJ/275-P8M3-PA), and HA-N394T (rSJ/275-P8M3-HA) were generated by reverse genetics. A) Each virus was inoculated
at a multiplicity of infection of 0.01 TCID50/cell onto MDCK cells. Supernatants were collected at the indicated time points and titrated in MDCK cells by TCID50. B) Mice
(n¼5) were infected with 106 EID50 of the indicated virus and followed for weight loss. The numbers in the graphs indicated the numbers of surviving mice per group. C-D)
The parental SJ/275H6N1 virus (SJ/275) and recombinant viruses possessing PB2-E627K and PA-T97I (rSJ/275-P8M3-PB2/PA), PB2-E627K and HA-N394T (rSJ/275-P8M3-PB2/
HA), PA-T97I and HA-N394T (rSJ/275-P8M3-PA/HA), and PB2-E627K, PA-T97I, and HA-N394T (rSJ/275-P8M3-PB2/PA/HA) were generated by reverse genetics. C) Each virus
was inoculated at a multiplicity of infection of 0.01 TCID50/cell onto MDCK cells. Supernatants were collected at the indicated time points and titrated in MDCK cells by
TCID50. D) Mice (n¼5) were infected with 106 EID50 of the indicated virus and followed for weight loss. The numbers in the graphs indicated the numbers of surviving mice
per group.
Fig. 3. Effects of amino acid mutations for replication and tropism of SJ/275 in vivo. A) Mice (n¼6) were inoculated intranasally with 104EID50 of the indicated virus. Viral
loads in the lungs of infected mice (n¼3/time point) were determined at 3 and 5 dpi in eggs by EID50. Results are expressed as log10 EID50/g of tissue. The dotted indicates the
lower limit of detection of infectious virus. B) Mice (n¼3) were inoculated intranasally with 106EID50 of the indicated virus. Viral loads in the lungs, nasal turbinates (NT),
brains, intestines, livers, spleens, and kidneys were determined at 3 dpi in eggs by EID50. The dotted indicates the lower limit of detection of infectious virus.
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PB2-E627K substitution is the dominant contributor to viral
virulence in the mouse-adapted viruses (Fig. 2D).
We determined the MLD50 of the rSJ/275-P8M3-PB2/PA, rSJ/
275-P8M3-PB2/HA, rSJ/275-P8M3-PA/HA, and rSJ/275-P8M3-PB2/
PA/HA viruses were 3.25 log10 EID50, 5 log10 EID50, 5.5 log10 EID50,
and 3.5 log10 EID50, respectively (Table 1), indicating that the
PA-T97I and PB2-E627K substitutions displayed the greatest
enhancement of virulence in mice.
We sought to map the expanded tissue tropism of the adapted
viruses using recombinant viruses possessing one of the three
amino acid substitutions. Mice were ﬁrst inoculated intranasally
with 106 EID50 of WT SJ/275 or a recombinant virus possessing
either PB2-E627K, PA-T97I, or HA-N394T, and virus replication in
the lungs, nasal turbinates (NT), brains, intestines, livers, spleens,
and kidneys of infected animals was determined on day 3 post-
infection (Fig. 3B). The recombinant virus possessing PB2-E627K
replicated to higher titers in the lungs and NT when compared to
the WT SJ/275 virus and the PA-T97I and HA-N394T viruses
(Fig. 3B). However, none of the recombinant viruses possessing
single amino acid substitutions was detected in the brains 3 days
post-infection (Fig. 3B). When recombinant viruses possessing
combinations of mouse-adapting amino acid substitutions were
evaluated, viruses harboring PB2-E627K and PA-T97I were recov-
ered from the brain, indicating a requirement for both amino acid
substitutions for extrapulmonary replication in the brain (Fig. 3B).
Taken together, these data show that the PB2-E627K substitution
is a prerequisite for enhanced pathogenicity of the H6N1 virus in
mice, but that additional adaptive changes in the PA protein can
further enhance replicative capacity and expand viral tropism.
The combination of PB2-E627K and PA-T97I enhances viral
polymerase activity to a greater extent than PB2-E627K or PA-T97I
alone
The enhanced replication of viruses possessing PB2-672K
and/or PA-T97I in vitro and in vivo suggested that these amino
acid substitutions could impact viral polymerase activity. We
applied a mini-genome reporter assay to assess the impact of
mouse-adaptive changes in the PB2 and PA polymerase proteins
on the transcription and replication of viral RNAs (vRNAs) in
human 293T cells. We found that the PB2-E627K substitution
alone increased polymerase activity about 57-fold and PA-T97I
alone increased the polymerase activity about 14-fold when
compared to WT SJ/275 polymerase activity (Fig. 4). A polymerase
complex possessing both PB2-E627K and PA-T97I substitutions
increased polymerase activity about 75-fold compared to WT SJ/
275 polymerase activity (Fig. 4). These results suggest that the
enhanced replication of viruses harboring both PB2-E627K and PA-
T97I in vitro and in vivo is in part due to enhanced polymerase
activity.
Discussion
H6 viruses isolated from waterfowl have also shown the
capacity to infect humans via experimental inoculation (Beare
and Webster, 1991), and the ﬁrst naturally-acquired human case of
H6N1 has recently been reported in Taiwan, raising public health
concern (Yuan et al., 2013). However, the mechanisms of mam-
malian adaptation and interspecies transmission of H6N1 avian
inﬂuenza viruses remain poorly understood.
Here we have identiﬁed several amino acid substitutions that
substantially enhance the polymerase activity of an H6N1 virus in
mammalian cells, increase replication kinetics in vitro and in vivo,
and result in increased viral virulence and expanded tissue tropism.
In this report, we document that the PB2-E627K substitution was
necessary to enhance the replicative capacity and pathogenicity of
an H6N1 virus in a mouse model. In our study, we have also shown
that this mutation in PA contributes to the enhancement of
polymerase activity of an avian H6N1 virus in mammalian cells,
and is essential for mammalian host adaptation. PA-T97I substitu-
tion enhance the virulence of the H6N1 AIVs in a mouse model
(Fig. 2B and Fig. 3A) but not greatly (the MLD50 of rSJ/275-P8M3-PA
is46.5 log10EID50), although polymerase activity of this mutant
was markedly enhanced compared to wild type H6N1, unlike the
role of PA-T97I substitution in H5N2 AIVs (Song et al., 2009). A
similar observation was also made using 2009 pandemic H1N1
viruses, in which introduction of virulence markers E627K, D701N,
and E677G amino acid substitutions in the PB2 protein increased
polymerase complex reporter activity, but did not enhance viral
virulence in mice and ferrets (Herfst et al., 2010). While a H6N1
mutant containing PA-T97I alone was not lethal in mice at an
infecting dose of 106 EID50, a mutant virus containing both PB2-
E627K and PA-T97I had a much stronger inﬂuence on the patho-
genicity of H6N1 AIVs, suggesting a cooperative effect of these
adaptive changes within the polymerase complex.
We investigated the mechanisms responsible for the increased
pathogenicity rendered by the combination of PB2-E627K and PA-
T97I in vitro and in vivo. We found that viruses containing only a
single adaptive amino acid substitution replicated to titers similar
to that of the WT H6N1 virus in MDCK cells (Fig. 2A). However, the
virus containing PB2-E627K and PA-T97I replicated to ten-fold
higher titers than the WT H6N1 virus, demonstrating a synergistic
relationship of these adaptive changes on H6N1 replication in
mammalian cells (Fig. 2C). It is not clear that although the E627K
mutant virus showed high pathogenicity in mouse study, it only
showed mild increase in titer at 24 h post-infection in cell culture.
Considering that the presence of both the PB2-E627K and PA-T97I
amino acid substitutions, resulted in obvious increased viral titers
in MDCK cells when compared to the WT SJ/275 virus, the PA-T97I
substitution may be prerequisite for the increased viral replicative
capability that rendered by the PB2-E627K in MDCK cells.
Amino acid substitutions in the viral polymerase complex, a
heterotrimer composed of three subunits, PB2, PB1, and PA,
represent one of the major adaptive mechanisms that avian
inﬂuenza viruses exploit for efﬁcient replication, transmission,
and pathogenesis in mammals (Gao et al., 2009; Herfst et al.,
2010; Llompart et al., 2014; Ma et al., 2011; Ozawa et al., 2011;
Shinya et al., 2004; Steel et al., 2009; Subbarao et al., 1993; Sun
et al., 2014; Suzuki et al., 2014; Van Hoeven et al., 2009; Zhang
Fig. 4. Viral polymerase activity of RNP complexes. 293T cells were transfected
with a luciferase reporter plasmid (paviPolI-T-Luc) that expresses a negative-sense
virus-like RNA encoding a destabilized ﬁreﬂy luciferase enzyme, and one plasmid
for each of the proteins in the polymerase complex (NP, PB1, PB2, and PA).
Transfection conditions in which plasmids encoding an adaptive substitution at
PB2-627 and/or PA-97 were included in place of the wild-type plasmids are
indicated. Cells were also cotransfected with a Renilla luciferase expression plasmid
to control for transfection efﬁciency. Thirty-six hours post-transfection, ﬁreﬂy and
Renilla luciferase levels were measured, and Renilla expression was used to
normalize the data. The temperature used for the polymerase activity study is
37 1С. The averages of triplicate experiments are shown. Error bars represent the
standard deviation (SD).
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et al., 2012b). All three subunits, PB2, PB1, and PA, are required for
both transcription and replication of inﬂuenza virus. PB2 includes
the capped-RNA recognition domain, PB1 carries the polymerase
active site, and PA holds the endonuclease active site and has
critical roles in endonuclease activity of the inﬂuenza virus
polymerase (Braam et al., 1983; Dias et al., 2009; Horisberger,
1980; Nagata et al., 2008; Yuan et al., 2009). We subsequently
focused on the impact of adaptive amino acid substitutions on the
function of the viral RNA-dependent RNA polymerase (RDRP)
using a luciferase-based mini-genome assay to better understand
how the PB2-E627K/PA-T97I combination led to enhanced produc-
tion of infectious virus particles during in vitro and in vivo
replication. Although the RDRP containing PB2-E627K or PA-T97I
alone showed higher luciferase expression compared to wild-type
H6N1, the RDRP containing the PB2-E627K/PA-T97I combination
had the highest (75-fold) luciferase expression (Fig. 4). Impor-
tantly, the RDRP activity of polymerase complex proteins with
single or combined amino acid substitutions closely correlated
with the replication of viruses harboring those amino acid sub-
stitutions in MDCK cells and murine lungs (Fig. 2A and C and
Fig. 3A). Collectively, our data show that these PB2 and PA amino
acid substitutions strongly contribute to the adaptation of H6N1
AIVs in mammals.
In conclusion, we demonstrated that a combination of the PB2-
E627K and PA-T97I amino acid substitutions identiﬁed in the
H6N1 mouse-adapted strains comprised the primary virulence
determinant responsible for the increased pathogenicity and
adaptation of H6N1 AIVs in mice. Our data suggest that the
increased pathogenicity of viruses harboring both PB2-E627K
and PA-T97I amino acid substitutions is due to increased activity
of the polymerase complex which translates to improved replica-
tion in mammalian cells.
Materials and methods
Facilities
Studies with H6N1 AIVs were conducted in a biosecurity level
3 laboratory approved by the Military Veterinary Research Insti-
tute of the Academy of Military Medical Sciences. All animal
studies were approved by the Review Board of Military Veterinary
Research Institute of the Academy of Military Medical Sciences.
Cells and virus
Madin-Darby canine kidney (MDCK) cells were cultured in
Dulbecco's Modiﬁed Eagle's Medium (DMEM) supplemented with
5% fetal calf serum (FCS), 100 IU/ml penicillin, 100 mg/ml strepto-
mycin, 2 mM glutamine. 293 T cells were cultured in DMEM
supplemented with 10% FCS, 100 IU/ml penicillin, 100 mg/ml
streptomycin, 2 mM glutamine. The H6N1 virus A/Mallard/San-
Jiang/275/2007 (abbreviated as SJ/275), was isolated from an anal
swab of a mallard in Sanjiang natural reserve of Heilongjiang
province, China (Cheng et al., 2014). Stock viruses were grown in
the allantoic cavities of 10-day-old chicken eggs for 60 h at 37 1C,
and aliquots were stored at 80 1C until used. The GenBank
accession numbers corresponding to each of the eight SJ/275 viral
gene segments are KJ021045-KJ021052.
Virus titration in eggs and MDCK cells
Virus titers in virus stocks and homogenized organ samples
were determined by end-point titration in eggs and/or MDCK cells.
For end-point viral titration in eggs, ten-fold serial dilutions of each
sample were inoculated into eggs. Sixty hours after inoculation,
ﬂuid from the allantoic cavity was collected and tested for the
ability to agglutinate chicken erythrocytes as an indicator of virus
replication. Infectious virus titers were reported as log10 EID50 /ml
or log10EID50/g, and were calculated from 3 replicates by the
method of Reed–Muench (Matumoto, 1949). For end-point viral
titration on MDCK cells, ten-fold serial dilutions of each sample
were inoculated onto MDCK cell monolayers grown in a 96 well
culture plate. One hour after inoculation, the monolayer was
washed with phosphate-buffered saline (PBS), and cultured in
100 ml of DMEM supplemented with 100 IU/ml penicillin, 100 mg/ml
streptomycin, 2 mM glutamine, and 2 mg/ml TPCK-treated trypsin.
Seventy-two hours after inoculation, supernatants of infected cell
cultures were tested for agglutinating activity using chicken ery-
throcytes as an indicator of virus replication. Infectious virus titers
were calculated from 3 replicates by the method of Reed–Muench
(Matumoto, 1949), and expressed as log10 TCID50/ml.
RNA isolation, PCR ampliﬁcation, and sequencing
Viral RNA was isolated from the allantoic ﬂuid of inoculated
eggs using the RNeasy Mini kit (QIAGEN, Germantown, MD)
according to the manufacturer's protocol. Reverse transcription
of viral RNA and subsequent PCR were performed using primers
speciﬁc for each gene segment (sequences available upon request).
PCR products were puriﬁed using the QIAquick PCR puriﬁcation kit
(QIAGEN, Germantown, MD) according to the manufacturer's
protocol. Viral gene segments were sequenced by the Beijing
Genomics Institute (Beijing, China). DNA sequences were analyzed
and compared to the parental SJ/275 virus using the Lasergene
sequence analysis software package (DNASTAR, Madison, WI).
Rescue of viruses by reverse genetics
We used an eight-plasmid reverse genetics system for virus
rescue as described previously (Li et al., 2005). We inserted the
cDNA derived from SJ/275 or MA-P8M3 viral genes between the
ribozyme and polymerase I promoter sequence. The plasmids used
for transfection were prepared using the QIAﬁlterTM Plasmid Midi kit
(QIAGEN). Recombinant viruses rSJ/275-P8M3-PB2, rSJ/275-P8M3-
PA, rSJ/275-P8M3-HA, rSJ/275-P8M3-PB2/PA, rSJ/275-P8M3-PB2/HA,
rSJ/275-P8M3-PA/HA, and rSJ/275-P8M3-PB2/PA/HA were rescued in
293 T cells using reverse genetics as previously described (Gao et al.,
2009; Li et al., 2005), and propagated in MDCK cells. All the
constructs were completely sequenced to ensure the absence of
unwanted mutations.
In vivo experiments
The 50% mouse lethal dose (MLD50) of the parental SJ/275 virus
and the recombinant viruses was measured using groups of three
female 4–6-week-old BALB/c mice (Merial-Vital Laboratory Animal
Technology Co., Ltd., Beijing, China). Mice were intranasally
inoculated with 50 μl of 10-fold serial dilutions of each indicated
inﬂuenza virus in PBS under isoﬂuorane sedation, with doses
ranging from 101–106 EID50. Survival and body weight changes
were recorded daily for 14 days post-infection (dpi). Animals that
showed signs of severe disease and weight loss 425% of their
initial body weight were considered moribund and were huma-
nely sacriﬁced. MLD50 values were calculated by the Reed–Muench
method (Matumoto, 1949) after a 14-day observation period and
expressed as EID50.
To evaluate the impact of individual amino acid substitutions
alone and in combination on morbidity and mortality, we inocu-
lated groups of ﬁve mice with 106 EID50 SJ/275 or recombinant
H6N1 variant viruses harboring different adaptive amino acid
substitutions and recorded weight loss and mortality for 14 dpi.
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Mice were additionally intranasally inoculated with 104 EID50 of
the indicated viruses to measure the replicative capacity of
recombinant viruses as compared to the parental SJ/275 virus in
the lungs. Three mice in each group were euthanized at 3 and
5 dpi. The lungs were collected, homogenized, and tissue debris
was removed by low-speed centrifugation. Virus titers of each
sample were determined by endpoint titration in eggs as described
above, and virus titers of each strain were expressed as mean
log10EID50/g7standard deviation (SD). To evaluate the tropism
and replication capacity of each virus in vivo, we euthanized three
mice on 3 days after inoculation with 106 EID50 SJ/275 or
recombinant H6N1 viruses and harvested the lungs, nasal turbi-
nates (NT), brains, intestines, livers, spleens, and kidneys. Organs
were homogenized in 1 ml of PBS and viral titers in each of the
organs were determined by titration in chicken eggs. Titers were
calculated by the Reed–Muench method (Matumoto, 1949) and
expressed as mean log10EID50/g7standard deviation (SD). The
limit of virus detection was 0.75 log10EID50/g. For calculation of the
mean, samples with a virus titer ofo0.75 log10EID50/g were
assigned a value of 0.
Analysis of replication kinetics in MDCK cells
MDCK cells were infected with indicated inﬂuenza viruses at a
multiplicity of infection (MOI) of 0.01 TCID50 (50% tissue culture
infectious dose)/cell. After incubation, the cells were washed and
overlaid with DMEM containing 2 mg/ml TPCK-treated trypsin.
Supernatants were collected 12, 24, 36, 48, 60, 72, and 84 h after
infection and stored at 80 1C. Virus titer was determined by end-
point titration in MDCK cells. Virus titers of each virus in different
time points were expressed as mean log10 TCID50/ml7standard
deviation (SD).
Minigenome assay for polymerase activity
Polymerase activity was measured using a minigenome assay
as previously described (Song et al., 2011), and the temperature
used for the polymerase activity study is 37 1С. In brief subcon-
ﬂuent monolayers of 293 T cells were transfected with a luciferase
reporter plasmid (paviPolI-T-Luc) together with the pTK-RL (Pro-
mega) and pcDNA3.1þ plasmid constructs encoding the polymer-
ase genes PB2, PB1, PA, and NP using Lipofectamine 2000
(Invitrogen) as recommended by the manufacturer. pTK-RL
expresses Renilla luciferase and was used as an internal transfec-
tion control for the dual luciferase assay. After eight hours, the
medium was replaced with DMEM containing 10% FCS. Cell
extracts were harvested 36 h post-transfection and luciferase
activity was assayed by using the Luciferase assay system (Pro-
mega). The assay was standardized against the Renilla luciferase
activity. Experiments were performed in triplicate.
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